More than 6 million Americans are currently living with Alzheimer's, and that number is only expected to increase. In fact, estimates now show that this number could rise to nearly 13 million by 2050.
To help optimize the care of patients living with this debilitating condition, Spotlight on Alzheimer’s Disease features leading neurologists and other allied healthcare professionals sharing their insights on the latest diagnostic and treatment advances.
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
PBA Treatment May Reverse Signs of Alzheimer’s Disease
PBA Treatment May Reverse Signs of Alzheimer’s Disease
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting